EPO and diabetic kidney disease: Second, reactive oxygen species (ROS) induce endothelial cell dysfunction, subsequently leading to glomerular diseases, including diabetic nephropathy [61,62], as well as hypoxic conditions involved in EPO-mediated erythropoiesis.